NVIDIA, Intel, Marvell, and Other AI Stocks Plunged Today
The AI rally cooled as major chip makers like NVIDIA, Intel, and Marvell pulled back. This article breaks down why th...
What Are Some Tax Planning Strategies
Some tax planning strategies can significantly reduce your tax bill. Learn about key techniques to improve your financial strategy.
23,434 articles
This AI-Driven World Tests Boehly's Leadership Today
Tod Boehly argues that admitting uncertainty is a strength in an AI-powered era. This guide explores what that means ...
Energy Refuses Quit: Stocks Surge as Oil Climbs Across Markets
Energy refuses quit: stocks keep leading gains into June 2026, with the XLE ETF rising and major oil names driving th...
Claude Code Discovery Triggers Billion-Dollar Bug Today
A security researcher leveraged Claude-powered tooling to reveal a long-standing vulnerability in Zcash's Orchard cir...
Ripple Expands XRP Settlement with Bitso MXNB
Ripple announces a major expansion with Bitso to bring MXNB to the XRP Ledger, linking peso liquidity with RLUSD for ...
JPMorgan Chase Eyeing Interest Growth: 7% NII Target
JPMorgan Chase has set a bold 7% net interest income growth goal for 2026. This article explains why the target could...
Here Group (HERE) 2026 Q3 Earnings: Key Takeaways & Tips
Here Group's Q3 2026 earnings reveal where the company is growing and where risks lurk. This article breaks down the ...
Three Reasons Micron Smart Before June 24 Earnings
As Micron prepares to report on June 24, three solid reasons could justify a closer look at MU. This guide breaks dow...
STRC’s Plunge Puts Saylor’s Bitcoin Dividend at Risk
STRC slid to a deep intraday low near $82.61 on June 18 before rebounding, signaling distress in the Bitcoin-linked d...
What Will Nvidia’s Stock Price Look Like by 2029
Nvidia sits at the center of a rapid AI infrastructure buildout. Here’s how the stock could move by 2029, based on gr...
Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status